{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T13:07:24Z","timestamp":1779541644947,"version":"3.53.1"},"reference-count":24,"publisher":"Central Research Institute for Epidemiology","issue":"2","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["virusjour.crie.ru"],"crossmark-restriction":false},"short-container-title":["Problems of Virology"],"abstract":"<jats:p>Introduction. Measles, mumps and rubella viruses are highly contagious viruses that can cause serious clinical outcomes, complications and death. Neutralizing antibodies against measles, mumps and rubella viruses are a good indicator of clinical protection against these infections, but they are difficult to measure.\r\nThe aim. To develop a serological glycoprotein-based passive hemagglutination reaction (gpPHAR) tests for the detection of neutralizing antibodies to measles, mumps and rubella viruses.\r\nMaterials and methods. Human and animal cell cultures from the collection of the I.I. Mechnikov Research Institute of Vaccines and Sera were used; vaccine strains of measles, mumps and rubella viruses; monoclonal antibodies to measles and rubella virus glycoproteins, human and animal immune sera; formalized sheep erythrocytes sensitized with viral glycoproteins; virus neuralization test (VNT), gpPHAR and gpELISA.\r\nResults. Viral glycoproteins of measles, mumps, and rubella were extracted from infected cell cultures. Comparative titrations of human and animal immune sera to measles, mumps, and rubella viruses in VNT, gpPHAR, and gpELISA have been performed. Unambiguous titers of neutralizing antibodies have been established. Titration of homologous and heterologous immune sera to three viruses was performed in the gpPHAR. The absence of cross-immunoreactivity to other viral agents has been established. The titers of the immune sera of patients with measles, mumps, and rubella infections were determined in the gpPHAR and gpELISA assays. Identical titers of neutralizing antibodies were found in both serological tests.\r\nConclusion. The gpPHAR serological tests has been developed to evaluate neutralizing virus-specific antibodies to measles, mumps and rubella in patients.<\/jats:p>","DOI":"10.36233\/0507-4088-354","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:12:15Z","timestamp":1778429535000},"page":"127-138","update-policy":"https:\/\/doi.org\/10.36233\/0372-9311-crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Serological tests based on viral glycoproteins for detecting neutralizing antibodies to measles, mumps and rubella viruses"],"prefix":"10.36233","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8204-4899","authenticated-orcid":false,"given":"Firaya G.","family":"Nagieva","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3369-8869","authenticated-orcid":false,"given":"Elena P.","family":"Barkova","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-9610","authenticated-orcid":false,"given":"Olga S.","family":"Kharchenko","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-8295","authenticated-orcid":false,"given":"Alexander V.","family":"Sidorov","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8707-7710","authenticated-orcid":false,"given":"Natalia N.","family":"Vlasova","sequence":"additional","affiliation":[{"name":"Federal Scientific Center \u2013 All-Russian Research Institute of Experimental Veterinary Medicine named after K.I. Skryabin and Ya.O. Kovalenko, Russian Academy of Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0821-5553","authenticated-orcid":false,"given":"Olga A.","family":"Trubacheva","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3226-5989","authenticated-orcid":false,"given":"Yulia N.","family":"Tarakanova","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5346-8104","authenticated-orcid":false,"given":"Vladislav V.","family":"Semerikov","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Educational Institution of Higher Education Perm State Pharmaceutical Academy of the Ministry of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-687X","authenticated-orcid":false,"given":"Alfiya K.","family":"Tagirova","sequence":"additional","affiliation":[{"name":"First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8771-4177","authenticated-orcid":false,"given":"Dinora A.","family":"Yakovleva","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-4581","authenticated-orcid":false,"given":"Evgeny A.","family":"Pashkov","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"},{"name":"First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6365-7147","authenticated-orcid":false,"given":"Ekaterina S.","family":"Osipova","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5845-5059","authenticated-orcid":false,"given":"Anastasiya M.","family":"Polisadova","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-8389","authenticated-orcid":false,"given":"Oksana A.","family":"Svitich","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"},{"name":"First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5808-2246","authenticated-orcid":false,"given":"Vitaly V.","family":"Zverev","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute of Vaccines and Sera"},{"name":"First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22004","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Lutz C.S., Nguyen H.Q., McClure D.L., Masters N.B., Chen M.H., Colley H., et al. Patterns of decline in measles, mumps, and rubella neutralizing antibodies and protection levels through 10 years after a second and third dose of MMR vaccine. Open Forum Infect. Dis. 2025; 12(4): ofaf188. https:\/\/doi.org\/10.1093\/ofid\/ofaf188","DOI":"10.1093\/ofid\/ofaf188"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Kuter B.J., Marshall G.S., Fergie J., Schmidt E., Pawaskar M. Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII. Hum. Vaccin. Immunother. 2021; 17(12): 5372\u201383. https:\/\/doi.org\/10.1080\/21645515.2021.2007710","DOI":"10.1080\/21645515.2021.2007710"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Bellini W.J., Icenogle J.P., Hickman C.J. Measles, mumps, and rubella viruses. In: Loffelholz M.J., Hodinka R.L., Young S.A., Pinsky B.A., eds. Clinical Virology Manual. ASM Press; 2016. https:\/\/doi.org\/10.1128\/9781555819156.ch21","DOI":"10.1128\/9781555819156.ch21"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Dardis M.R. A review of measles. J. Sch. Nurs. 2012; 28(1): 9\u201312. https:\/\/doi.org\/10.1177\/1059840511429004","DOI":"10.1177\/1059840511429004"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Griffin D.E. Measles virus and the nervous system. Handb. Clin. Neurol. 2014; 123: 577\u201390. https:\/\/doi.org\/10.1016\/b978-0-444-53488-0.00027-4","DOI":"10.1016\/B978-0-444-53488-0.00027-4"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Boehlen J.Y., Balavoine J.F., de Moerloose P. Severe thrombocytopenic purpuradue to rubella infection in a patient with systemic lupus erythematosus. Lupus. 2003; 2(2): 144\u20136. https:\/\/doi.org\/10.1191\/0961203303lu279cr","DOI":"10.1191\/0961203303lu279cr"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Marks M., Marks J.L. Viral arthritis. Clin. Med. (Lond.). 2016; 16(2): 129\u201346. https:\/\/doi.org\/10.7861\/clinmedicine.16-2-129","DOI":"10.7861\/clinmedicine.16-2-129"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Ai J., Xie Z., Liu G., Chen Z., Yang Y., Li Y., et al. Etiology and prognosis of acute viral encephalitis and meningitis in Chinese children: a multicentre prospective study. BMC Infect. Dis. 2017; 17(1): 494. https:\/\/doi.org\/10.1186\/s12879-017-2572-9","DOI":"10.1186\/s12879-017-2572-9"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lee J.Y., Bowden D.S. Rubella virus replication and links to teratogenicity. Clin. Microbiol. Rev. 2000; 13(4): 571\u201387. https:\/\/doi.org\/10.1128\/cmr.13.4.571","DOI":"10.1128\/CMR.13.4.571"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Das P.K., Kielian M. Rubella virus assembly requirements and evolutionary relationships with novel rubiviruses. Virology. 2024; 15(10): e0196524. https:\/\/doi.org\/10.1128\/mbio.01965-24","DOI":"10.1128\/mbio.01965-24"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Relich R.F., Theel E.S. Measles, Mumps, and Rubella viruses. In: Schmitz J.L., Detrick B., O\u2019Gorman M.R.G. Manual of Molecular and Clinical Laboratory Immunology. American Society for Microbiology; 2024. https:\/\/doi.org\/10.1002\/9781683674023.ch56","DOI":"10.1002\/9781683674023.ch56"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Leland D.S. Chapter: 85. Parainfluenza and mumps viruses. In: Manual of Clinical Microbiology. ASM Press; 2015: 1347\u201356. https:\/\/doi.org\/10.1128\/9781555817381.ch85","DOI":"10.1128\/9781555816728.ch82"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Loomis R.J., Lai Y.T., Sowers S.B., Stewart-Jones G.B.E. Structure-based design of glycoprotein subunit vaccines for mumps. Proc. Natl Acad. Sci. USA. 2024; 121(47): e2404053121. https:\/\/doi.org\/10.1073\/pnas.2404053121","DOI":"10.1073\/pnas.2404053121"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Rubin S., Eckhaus M., Rennick L.J., Bamford C.G., Duprex W.P. Molecular biology, pathogtnesis and pathology of mumps virus. J. Pathol. 2015; 235(2): 242\u201352. https:\/\/doi.org\/10.1002\/path.4445","DOI":"10.1002\/path.4445"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"\u0160antak M., Lang-Balija M., Ivancic-Jelecki J., Ko\u0161uti\u0107-Gulija T., Ljubin-Sternak S., Forcic D. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies. Epidemiol. Infect. 2013; 141(6): 1298\u2013309. https:\/\/doi.org\/10.1017\/s0950268812001896","DOI":"10.1017\/S0950268812001896"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Frost J.R., Shaikh S., Severini A. Exploring the mumps virus glycoproteins: a review. Viruses. 2022; 14(6): 1335. https:\/\/doi.org\/10.3390\/v14061335","DOI":"10.3390\/v14061335"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Mankertz A., Chen M.H., Goldberg T.L., H\u00fcbschen J.M., Pfaff F., Ulrich R.G., et al. ICTV virus taxonomy profile: Matonaviridae 2022. J. Gen. Virol. 2022; 103(12): 001817. https:\/\/doi.org\/10.1099\/jgv.0.001817","DOI":"10.1099\/jgv.0.001817"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Frey T.K. Molecular biology of rubella virus. Adv. Virus Res. 1994; 44: 69\u2013160. https:\/\/doi.org\/10.1016\/s0065-3527(08)60328-0","DOI":"10.1016\/S0065-3527(08)60328-0"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Chaye H., Chong P., Tripet B., Brush B., Gillam S. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus. Virology. 1992; 189(2): 483\u201392. https:\/\/doi.org\/10.1016\/0042-6822(92)90572-7","DOI":"10.1016\/0042-6822(92)90572-7"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Cordoba P., Grutadauria S., Cuffini C., Zapata M. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in Vero cells. Viral. Immunol. 2000; 13(1): 83\u201392. https:\/\/doi.org\/10.1089\/vim.2000.13.83","DOI":"10.1089\/vim.2000.13.83"},{"key":"ref21","unstructured":"Anjaparidze O.G., Nagieva F.G., Maltseva N.N., Nikulina V.G., Vedunova S.L., Zvonarev A.Yu., Krasnova N.I., Kuznetsova E.I., Barkova E.P., Khodorovskaya E.G., Etkind G.V. Preparation and properties of hybridomas producing monoclonal antibodies to measles virus Leningrad 16. Questions of virology. 1989; 34(2): 204\u20137."},{"key":"ref22","unstructured":"Nagieva F.G., Nikulina V.G., Barkova E.P., Zubkov A.V., Kuz\u2019mina N.S., Desyatskova R.G., et al. Monoclonal antibodies to Rubella virus glycoprotein E1. Zhurnal mikrobiologii, epidemiologii i immunologii. 2011; (1): 61\u20137. https:\/\/elibrary.ru\/qbbztr (in Russian)"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Nagieva F.G., Barkova E.P., Kharchenko O.S., Sidorov A.V., Alatortseva G.I., Cherepovich B.S., et al. A simple, highly sensitive and specific serological test for the detection of antibodies to Varicella-Zoster virus (Varicellovirus humanalpha3). Voprosy virusologii. 2024; 69(6): 489\u201399. https:\/\/doi.org\/10.36233\/0507-4088-259 https:\/\/elibrary.ru\/ykzhop (in Russian)","DOI":"10.36233\/0507-4088-259"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Vittrup D.M., Jensen A., Malon M., Zimakoff A.C., Kiehn S\u00f8rensen J., Littell B., et al. Comparison of measles plaque reduction neutralization test (PRNT) and measles virus-specific IgG ELISA for assessment of immunogenicity of measles-mumps-rubella vaccination at 5-7 months of age and maternal measles antibodies. Vaccine X. 2024; 20: 100548. https:\/\/doi.org\/10.1016\/j.jvacx.2024.100548","DOI":"10.1016\/j.jvacx.2024.100548"}],"container-title":["Problems of Virology"],"original-title":[],"link":[{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16820\/1091","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/16820\/1091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:41:14Z","timestamp":1779540074000},"score":1,"resource":{"primary":{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/view\/16820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,8]]}},"URL":"https:\/\/doi.org\/10.36233\/0507-4088-354","relation":{},"ISSN":["2411-2097","0507-4088"],"issn-type":[{"value":"2411-2097","type":"electronic"},{"value":"0507-4088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}